- $178.83bn
- $209.74bn
- $67.06bn
- 98
- 41
- 98
- 93
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 53,800 | 41,748 | 50,971 | 59,427 | 67,060 |
Cost of Revenue | |||||
Gross Profit | 17,292 | 12,709 | 15,517 | 18,292 | 24,403 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 45,510 | 37,195 | 44,093 | 51,523 | 54,094 |
Operating Profit | 8,290 | 4,553 | 6,878 | 7,904 | 12,966 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7,812 | 3,995 | 8,204 | 8,752 | 13,050 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,888 | 2,909 | 6,426 | 6,685 | 10,269 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 6,093 | 2,998 | 6,489 | 6,705 | 10,335 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6,093 | 2,998 | 6,489 | 6,705 | 10,335 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10.8 | 5.79 | 11.9 | 15.2 | 21.5 |
Dividends per Share |